NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced that it has been selected for inclusion in the Russell Microcap®, 3000®, and Global® Indexes, effective immediately.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. Inclusion confers eligibility for a number of growth and value stock indexes and corresponding funds. Russell criteria for membership in its equity indexes is based primarily on market capitalization and style attributes.
